Due to age, health conditions, and chronic illnesses, long-term care residents may be more susceptible to skin and wound issues. That is why Ontario is investing $1 million in education programs for ...
RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, announced today that it has completed patient enrollment in its Phase 2 clinical trial for Purified ...